These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Cardiac problems in the dialysis patient: beyond coronary disease. Remppis A; Ritz E Semin Dial; 2008; 21(4):319-25. PubMed ID: 18627566 [TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients. Halkin A; Selzer F; Marroquin O; Laskey W; Detre K; Cohen H J Invasive Cardiol; 2006 Dec; 18(12):577-83. PubMed ID: 17197706 [TBL] [Abstract][Full Text] [Related]
7. Sudden cardiac death and dialysis patients. Herzog CA; Mangrum JM; Passman R Semin Dial; 2008; 21(4):300-7. PubMed ID: 18627568 [TBL] [Abstract][Full Text] [Related]
8. Sudden death in hemodialysis: an update. Kanbay M; Afsar B; Goldsmith D; Covic A Blood Purif; 2010; 30(2):135-45. PubMed ID: 20798493 [TBL] [Abstract][Full Text] [Related]
9. [Cardiovascular diseases in dialysis patients]. Kooman JP; Leunissen KM Ned Tijdschr Geneeskd; 1999 May; 143(21):1084-7. PubMed ID: 10368743 [TBL] [Abstract][Full Text] [Related]
10. [Peritoneal dialysis and cardiopulmonary comorbidity]. Wiesholzer M Wien Klin Wochenschr; 2005; 117 Suppl 6():46-53. PubMed ID: 16437333 [TBL] [Abstract][Full Text] [Related]
11. Influence of interleukin-6 G-174C gene polymorphism on coronary artery disease, cardiovascular complications and mortality in dialysis patients. Aker S; Bantis C; Reis P; Kuhr N; Schwandt C; Grabensee B; Heering P; Ivens K Nephrol Dial Transplant; 2009 Sep; 24(9):2847-51. PubMed ID: 19349293 [TBL] [Abstract][Full Text] [Related]
12. Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients. Wang AY; Wang M; Woo J; Lam CW; Lui SF; Li PK; Sanderson JE J Am Soc Nephrol; 2004 Aug; 15(8):2186-94. PubMed ID: 15284304 [TBL] [Abstract][Full Text] [Related]
14. Mineralocorticoid receptor antagonists and cardiovascular mortality in patients with atrial fibrillation and left ventricular dysfunction: insights from the Atrial Fibrillation and Congestive Heart Failure Trial. O'Meara E; Khairy P; Blanchet MC; de Denus S; Pedersen OD; Levesque S; Talajic M; Ducharme A; White M; Racine N; Rouleau JL; Tardif JC; Roy D; Circ Heart Fail; 2012 Sep; 5(5):586-93. PubMed ID: 22798522 [TBL] [Abstract][Full Text] [Related]
15. Influence of dialysis therapies in the development of cardiac disease in CKD. Odudu A; McIntyre C J Ren Care; 2010 May; 36 Suppl 1():47-53. PubMed ID: 20586899 [TBL] [Abstract][Full Text] [Related]
16. Ventricular arrhythmias and sudden death in patients with chronic kidney disease. Green D; Roberts PR J Ren Care; 2010 May; 36 Suppl 1():54-60. PubMed ID: 20586900 [TBL] [Abstract][Full Text] [Related]
17. Myocardial stunning in hemodialysis: what is the overall message? Dorairajan S; Chockalingam A; Misra M Hemodial Int; 2010 Oct; 14(4):447-50. PubMed ID: 20955278 [TBL] [Abstract][Full Text] [Related]
18. Dialysis patients and cardiovascular problems: can technology solve the complex equation? Ronco C; Tetta C Expert Rev Med Devices; 2005 Nov; 2(6):681-7. PubMed ID: 16293095 [TBL] [Abstract][Full Text] [Related]